Lexeo Therapeutics, Inc. (LXEO) has 14 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $43K. Most recent filing: Aug. 19, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 19, 2026 filed Aug. 18, 2026 | Tamayo Louis Edward Chief Financial Officer | −$20,203 | 4,117 | −4% | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 18, 2026 | Otero Jose Manuel Chief Operating Officer | −$6,464 | 1,304 | −1% | No | |
|
|
||||||
| Aug. 19, 2026 filed Aug. 18, 2026 | Townsend Richard Nolan Chief Executive Officer | −$16,562 | 3,345 | −1% | No | |
|
|
||||||
| July 1, 2026 filed June 29, 2026 | Tamayo Louis Edward Chief Financial Officer | — | +7,359 | +8% | No | |
|
|
||||||
| July 1, 2026 filed June 29, 2026 | Otero Jose Manuel Chief Operating Officer | — | +7,394 | +6% | No | |
|
|
||||||
Showing the 5 most recent of 14 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free